198 related articles for article (PubMed ID: 23601457)
1. [Emphasizing the prevention and anti-inflammation research of dry eye disease].
Zhang MC; Bian F
Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):6-7. PubMed ID: 23601457
[TBL] [Abstract][Full Text] [Related]
2. The cellular mechanisms of dry eye: from pathogenesis to treatment.
Mantelli F; Massaro-Giordano M; Macchi I; Lambiase A; Bonini S
J Cell Physiol; 2013 Dec; 228(12):2253-6. PubMed ID: 23696296
[TBL] [Abstract][Full Text] [Related]
3. Antiinflammatory therapy for dry eye.
Pflugfelder SC
Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
[TBL] [Abstract][Full Text] [Related]
4. [Effect of anti-inflammatory therapy on the treatment of dry eye syndrome].
Mrukwa-Kominek E; Rogowska-Godela A; Gierek-Ciaciura S
Klin Oczna; 2007; 109(1-3):79-84. PubMed ID: 17687921
[TBL] [Abstract][Full Text] [Related]
5. Dry eyes: etiology and management.
Latkany R
Curr Opin Ophthalmol; 2008 Jul; 19(4):287-91. PubMed ID: 18545008
[TBL] [Abstract][Full Text] [Related]
6. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
7. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
8. [Dry eye syndrom--multispecialistic disease. Part two: diagnostic procedure and treatment].
Nowak M; Marek B; Kajdaniuk D; Siemińska L; Kos-Kudła B; Nowak K; Głogowska-Szelag J
Wiad Lek; 2011; 64(1):49-55. PubMed ID: 21812364
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of dry eye.
Dogru M; Tsubota K
Expert Opin Pharmacother; 2011 Feb; 12(3):325-34. PubMed ID: 21214414
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model.
Zhang Z; Yang WZ; Zhu ZZ; Hu QQ; Chen YF; He H; Chen YX; Liu ZG
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2963-74. PubMed ID: 24722696
[TBL] [Abstract][Full Text] [Related]
11. The role and treatment of inflammation in dry eye disease.
Yagci A; Gurdal C
Int Ophthalmol; 2014 Dec; 34(6):1291-301. PubMed ID: 25416345
[TBL] [Abstract][Full Text] [Related]
12. The treatment of dry eye.
Calonge M
Surv Ophthalmol; 2001 Mar; 45 Suppl 2():S227-39. PubMed ID: 11587147
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targets in dry eye syndrome.
Peral A; Domínguez-Godínez CO; Carracedo G; Pintor J
Drug News Perspect; 2008 Apr; 21(3):166-76. PubMed ID: 18560615
[TBL] [Abstract][Full Text] [Related]
14. [Conservative treatment of dry eye].
Hefner J; Reinshagen H
Klin Monbl Augenheilkd; 2014 Nov; 231(11):1093-6. PubMed ID: 25275793
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic inhibitors for the treatment of dry eye syndrome.
Rodríguez-Pomar C; Pintor J; Colligris B; Carracedo G
Expert Opin Pharmacother; 2017 Dec; 18(17):1855-1865. PubMed ID: 29115899
[TBL] [Abstract][Full Text] [Related]
16. Advancements in anti-inflammatory therapy for dry eye syndrome.
McCabe E; Narayanan S
Optometry; 2009 Oct; 80(10):555-66. PubMed ID: 19801339
[TBL] [Abstract][Full Text] [Related]
17. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
Wilson SE; Perry HD
Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
[TBL] [Abstract][Full Text] [Related]
18. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients.
Altiparmak UE; Acar DE; Ozer PA; Emec SD; Kasim R; Ustun H; Duman S
Eye (Lond); 2010 Jun; 24(6):1044-50. PubMed ID: 19834507
[TBL] [Abstract][Full Text] [Related]
19. [Anti-inflammatory treatment in dry eye disease].
Steven P; Cursiefen C
Klin Monbl Augenheilkd; 2012 May; 229(5):500-5. PubMed ID: 22592340
[TBL] [Abstract][Full Text] [Related]
20. Diclofenac protects cultured human corneal epithelial cells against hyperosmolarity and ameliorates corneal surface damage in a rat model of dry eye.
Sawazaki R; Ishihara T; Usui S; Hayashi E; Tahara K; Hoshino T; Higuchi A; Nakamura S; Tsubota K; Mizushima T
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2547-56. PubMed ID: 24677100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
